June 30, 2026

FDA Expands Pediatric Roflumilast Use

The expanded indication is supported by pharmacokinetic, safety, tolerability, exploratory efficacy, and long-term safety data from studies in children aged 2 to 5 years.

Conexiant

June 30, 2026

Top 10 Growing Metro Areas With Active HPSAs

These 10 metropolitan areas reported population gains and active federal shortage area designations identified in census and health care workforce data.

Conexiant

June 30, 2026

Low Weight Linked to Severe Pediatric COVID

Brazilian pediatric intensive care unit study found underweight status was associated with respiratory complications, longer hospitalization, and mortality among critically ill patients with COVID-19.

Conexiant

June 29, 2026

FDA Approves Pediatric Risankizumab

Approval expands risankizumab use to pediatric plaque psoriasis and psoriatic arthritis and includes a new 55-mg prefilled syringe for weight-based dosing in patients weighing less than 40 kg.

Conexiant

June 26, 2026

FDA Monthly Preview: Key July Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Conexiant

June 26, 2026

ASE Plenary: Progress, Priorities, and What’s Next

Efforts to align, sustain, and engage drove a year of growth for ASE.

Conexiant

June 26, 2026

Identity Formation May Shape Residency Emotions

A review of 56 qualitative studies found residents' emotional experiences were influenced by interactions among training demands, workplace relationships, and their evolving professional identity.

Conexiant

June 24, 2026

No Short-Term Brain Changes in Youth Soccer

Researchers tracked cognitive, behavioral, imaging, and biomarker outcomes in 129 adolescent athletes across one season.

Conexiant

June 22, 2026

Top 10 States Offering Large Physician Loan Repayment Programs

These states offer physician loan repayment and student loan forgiveness programs through state-supported workforce initiatives.

Conexiant

June 19, 2026

Fertility Issues May Be Linked to Autism

In a nationwide US cohort, parental subfecundity was associated with higher odds of autism spectrum disorder and modest increases in behavioral symptoms, while in vitro fertilization showed no statistically significant associations with neurodevelopmental outcomes.

Conexiant